These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1316069)

  • 21. Quinolone pharmacokinetics in the elderly.
    Schentag JJ; Goss TF
    Am J Med; 1992 Apr; 92(4A):33S-37S. PubMed ID: 1316067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.
    Bergogne-Bérézin E; Muller-Serieys C; Kafé H
    Am J Med; 1992 Apr; 92(4A):8S-11S. PubMed ID: 1316076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of sparfloxacin in patients with renal impairment.
    Fillastre JP; Montay G; Bruno R; Etienne I; Dhib M; Vivier N; Le Roux Y; Guimart C; Gay G; Schott D
    Antimicrob Agents Chemother; 1994 Apr; 38(4):733-7. PubMed ID: 8031038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue penetration and pharmacokinetics of lomefloxacin following multiple doses.
    Kavi J; Stone J; Andrews JM; Ashby JP; Wise R
    Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):168-70. PubMed ID: 2498102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Penetration of lomefloxacin into human prostatic tissue.
    Leroy A; Humbert G; Fillastre JP; Grise P
    Am J Med; 1992 Apr; 92(4A):12S-14S. PubMed ID: 1374582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple-dose pharmacokinetics of lomefloxacin: rationale for once-a-day dosing.
    Mant TG
    Am J Med; 1992 Apr; 92(4A):26S-32S. PubMed ID: 1316066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative studies on topical lomefloxacin and ciprofloxacin on ocular kinetic and experimental corneal ulcer.
    Velpandian T; Gupta SK; Gupta YK; Agarwal HC; Biswas NR
    J Ocul Pharmacol Ther; 1999 Dec; 15(6):505-11. PubMed ID: 10609773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of sparfloxacin in humans after single oral administration at doses of 200, 400, 600, and 800 mg.
    Montay G; Bruno R; Vergniol JC; Ebmeier M; Le Roux Y; Guimart C; Frydman A; Chassard D; Thebault JJ
    J Clin Pharmacol; 1994 Nov; 34(11):1071-6. PubMed ID: 7876398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of lomefloxacin in healthy volunteers: comparison of 400 milligrams once daily and 200 milligrams twice daily given orally for 5 days.
    Gros I; Carbon C
    Antimicrob Agents Chemother; 1990 Jan; 34(1):150-2. PubMed ID: 2327750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular distribution of lomefloxacin 0.3% after a single instillation in the infected eye of pigmented rabbits.
    Elena PP; Jauch A
    J Ocul Pharmacol Ther; 1997 Dec; 13(6):551-8. PubMed ID: 9436158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacin.
    Frost RW; Lettieri JT; Krol G; Shamblen EC; Lasseter KC
    Clin Pharmacol Ther; 1989 Jun; 45(6):608-16. PubMed ID: 2731404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of lomefloxacin on theophylline pharmacokinetics.
    Nix DE; Norman A; Schentag JJ
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1006-8. PubMed ID: 2675751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of lomefloxacin in human plasma by solid-phase extraction and high-performance liquid chromatography with UV detection.
    Carlucci G; Cilli A; Liberato M; Mazzeo P
    J Pharm Biomed Anal; 1993; 11(11-12):1105-8. PubMed ID: 8123720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review.
    Montay G
    J Antimicrob Chemother; 1996 May; 37 Suppl A():27-39. PubMed ID: 8737123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of lomefloxacin on the pharmacokinetics of theophylline.
    LeBel M; Vallée F; St-Laurent M
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1254-6. PubMed ID: 2393286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concentrations of lomefloxacin in radicular cyst and oral tissues following single or multiple oral administration.
    Akimoto Y; Mochizuki Y; Uda A; Omata H; Shibutani J; Nishimura H; Komiya M; Kaneko K; Kawana T; Fujii A
    J Nihon Univ Sch Dent; 1993 Dec; 35(4):267-75. PubMed ID: 8158288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraprostatic distribution of lomefloxacin following multiple-dose administration.
    Kovarik JM; de Hond JA; Hoepelman IM; Boon T; Verhoef J
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2398-401. PubMed ID: 2088193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid.
    Staib AH; Harder S; Fuhr U; Wack C
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):289-3. PubMed ID: 2737798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different effects of products containing metal ions on the absorption of lomefloxacin.
    Lehto P; Kivistö KT
    Clin Pharmacol Ther; 1994 Nov; 56(5):477-82. PubMed ID: 7955811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of age on the pharmacokinetics of temafloxacin.
    Granneman GR; Guay DR
    Am J Med; 1991 Dec; 91(6A):71S-75S. PubMed ID: 1662898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.